Crossmark

Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1007/s00262-018-2196-y

Published Online: 2018-07-04

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Barrera, Lourdes https://orcid.org/0000-0002-3758-2708
Montes-Servín, Edgar https://orcid.org/0000-0003-3746-6739
Hernandez-Martinez, Juan-Manuel https://orcid.org/0000-0002-7255-4438
Orozco-Morales, Mario

Montes-Servín, Elizabeth

Michel-Tello, David

Morales-Flores, Renato Augusto

Flores-Estrada, Diana

Arrieta, Oscar https://orcid.org/0000-0002-1164-3779
Funding

Funding for this research was provided by:

Consejo Nacional de Ciencia y Tecnología (87453, 161599)
License Information

Text and Data Mining valid from 2018-07-04
More Information

Article History

Received: 14 September 2017

Accepted: 29 June 2018

First Online: 4 July 2018

Compliance with ethical standards

:

: The authors declare that they have no conflicts of interest.

: This study was done in accordance with the provisions of the Declaration of Helsinki and Good Clinical Practice guidelines, under a protocol approved by the Ethics Committee and Institutional Review Board (IRB) of the Instituto Nacional de Cancerología (Mexico City, Mexico), [INCAN (011/018/ICI-CV/683)].

: All participants in this study provided written informed consent before any study-related procedures were performed.

Document is current

Any future updates will be listed below